Genetic markers of widespread extensively drug-resistant Pseudomonas aeruginosa high-risk clones.
about
Identification of novel genes responsible for overexpression of ampC in Pseudomonas aeruginosa PAO1Catalytic spectrum of the penicillin-binding protein 4 of Pseudomonas aeruginosa, a nexus for the induction of β-lactam antibiotic resistanceDeep sequencing analyses expands the Pseudomonas aeruginosa AmpR regulon to include small RNA-mediated regulation of iron acquisition, heat shock and oxidative stress response.Population structure of clinical Pseudomonas aeruginosa from West and Central African countries.Sequence types 235, 111, and 132 predominate among multidrug-resistant pseudomonas aeruginosa clinical isolates in Croatia.Antibiotic pressure is a major risk factor for rectal colonization by multidrug-resistant Pseudomonas aeruginosa in critically ill patientsDraft Genome Sequence of Colistin-Only-Susceptible Pseudomonas aeruginosa Strain ST235, a Hypervirulent High-Risk Clone in Spain.Identification of VIM-2-producing Pseudomonas aeruginosa from Tanzania is associated with sequence types 244 and 640 and the location of blaVIM-2 in a TniC integron.Clonal dissemination, emergence of mutator lineages and antibiotic resistance evolution in Pseudomonas aeruginosa cystic fibrosis chronic lung infection.Carbapenemase-producing Pseudomonas aeruginosa from central Greece: molecular epidemiology and genetic analysis of class I integrons.The β-lactamase gene regulator AmpR is a tetramer that recognizes and binds the D-Ala-D-Ala motif of its repressor UDP-N-acetylmuramic acid (MurNAc)-pentapeptidePrevalence of resistance to aminoglycosides and fluoroquinolones among Pseudomonas aeruginosa strains in a University Hospital in Northeastern Poland.Using multilocus sequence typing to study bacterial variation: prospects in the genomic era.Dissemination of VIM-2 producing Pseudomonas aeruginosa ST233 at tertiary care hospitals in Egypt.The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.Within-host microevolution of Pseudomonas aeruginosa in Italian cystic fibrosis patients.Pseudomonas aeruginosa AmpR: an acute-chronic switch regulator.Mutations in β-Lactamase AmpC Increase Resistance of Pseudomonas aeruginosa Isolates to Antipseudomonal Cephalosporins.Identification of extensive drug resistant Pseudomonas aeruginosa strains: New clone ST1725 and high-risk clone ST233.Antimicrobial resistance and virulence: a successful or deleterious association in the bacterial world?Draft Genome Sequence of VIM-2-Producing Multidrug-Resistant Pseudomonas aeruginosa ST175, an Epidemic High-Risk Clone.In Vitro Susceptibility of Global Surveillance Isolates of Pseudomonas aeruginosa to Ceftazidime-Avibactam (INFORM 2012 to 2014).Enhanced in vivo fitness of carbapenem-resistant oprD mutants of Pseudomonas aeruginosa revealed through high-throughput sequencing.Deciphering the Resistome of the Widespread Pseudomonas aeruginosa Sequence Type 175 International High-Risk Clone through Whole-Genome Sequencing.Multiple mutations lead to MexXY-OprM-dependent aminoglycoside resistance in clinical strains of Pseudomonas aeruginosaFingerprint Analysis and Identification of Strains ST309 as a Potential High Risk Clone in a Pseudomonas aeruginosa Population Isolated from Children with Bacteremia in Mexico CityRole of Pseudomonas aeruginosa AmpR on β-lactam and non-β-lactam transient cross-resistance upon pre-exposure to subinhibitory concentrations of antibioticsEvolution and impact of bacterial drug resistance in the context of cystic fibrosis disease and nosocomial settings.New perspectives in the management of Pseudomonas aeruginosa infections.Prevalence and risk factors associated with colonization and infection of extensively drug-resistant Pseudomonas aeruginosa: a systematic review.Pseudomonas aeruginosa: arsenal of resistance mechanisms, decades of changing resistance profiles, and future antimicrobial therapies.Evolution of Pseudomonas aeruginosa Antimicrobial Resistance and Fitness under Low and High Mutation Rates.Host and Pathogen Biomarkers for Severe Pseudomonas aeruginosa Infections.Convergent evolution and adaptation of Pseudomonas aeruginosa within patients with cystic fibrosis.Genomics and Susceptibility Profiles of Extensively Drug-Resistant (XDR) Pseudomonas aeruginosa from Spain.Management of multidrug-resistant Pseudomonas aeruginosa in the intensive care unit: state of the art.In Vivo Emergence of Resistance to Novel Cephalosporin-β-Lactamase Inhibitor Combinations through the Duplication of Amino Acid D149 from OXA-2 β-Lactamase (OXA-539) in Sequence Type 235 Pseudomonas aeruginosa.Determining β-lactam exposure threshold to suppress resistance development in Gram-negative bacteria.Acute Inflammatory Response of Patients with Pseudomonas aeruginosa Infections: A Prospective Study.The Threat and Response to Infectious Diseases (Revised).
P2860
Q28492757-A474AFA2-BE76-4788-B6DD-29E804A19E1EQ28493086-BFF9DC58-9991-419C-958F-B5FB810EF2FBQ29346787-66AF36FF-3366-45CE-BFB6-2764FE5553C9Q34134267-DB3C8807-B326-4235-B766-325245C234E4Q34298890-EE2F884E-FF8B-4984-985D-9BEFBCCE8E67Q34298982-FD00736F-6297-4614-B335-6306B21369C2Q34429763-8406CA5B-BD5F-4AC1-9A60-8DF2A0B24FCAQ34923207-55E8FF1B-2546-43E1-A678-2F78FBE4CB4EQ34948367-C3367B95-91A3-4514-8CCC-8319B88111B2Q35028183-AA63642F-26CB-4461-B6FB-78F9A2F326BDQ35048806-43796012-61CD-4B4A-93BB-BA4C03052907Q35069068-E582A6E3-EB12-4E30-A44C-782F72AB397DQ35193523-B7F1A415-0727-48DB-9268-4A89B7FD2587Q35404121-7CA7910A-47E0-4C70-9835-D4D4429C9046Q35482558-0EC17653-941B-4751-B44D-358A469F1BA3Q35813781-49A1BD31-335F-469F-B3E9-6F76A719B63DQ35975439-8321987B-CEFB-4979-8FC3-FCF840D84D52Q36075893-674A7048-7600-408C-9A76-6F29C25BC42BQ36295260-E2F0C2D8-F3C2-44D4-A173-03022AA34384Q36757725-D8AB429A-ABDC-4D51-A53E-8539E214E3EAQ36760871-B7D253C3-65D2-406C-9565-F230B8E929C8Q37120019-D3BCA682-6870-4B5E-81CA-2945214A8CEBQ37409391-E529B9F5-A84B-4872-9DBE-13E3DDB0FDD0Q37428703-F2A950B7-3F61-4552-AB7A-DED77B900C8CQ37544527-DB634268-E3B3-4988-8353-3368A5804AB4Q37672430-4F0144DF-D6F3-411D-BD32-BEB82FC4BC19Q37680591-FC375589-460F-4549-8E88-65E4B2345C85Q38211644-F9528210-C723-427A-8281-77336351A945Q38243221-D96CEF10-68DA-45B4-83D6-4BFD9A374CE9Q38543852-5F659CCF-8529-41AF-980A-9F1DD1D42EE6Q38599969-C6473C42-4320-4AFB-9838-ED40AE4D1E5DQ38741337-91756679-2D00-40CE-B20E-9FEBE0C6DE97Q38856197-18019D48-47B2-4856-B922-A470BE4C519EQ39097378-8C37B206-D4F6-4F79-97A7-DCC58F88BE5AQ40056971-59B53DF7-5D98-424B-9B29-6EA0C0823EF3Q40095692-DFC6F704-F7C9-4F9A-AF2A-F23201EEE03AQ40148490-B5730F40-B48B-47D7-833B-D0CBA9796BC0Q40346786-CDF89CCC-9B1B-4B45-A53F-0C5D9C9A3460Q40501527-3436E0BD-BE66-453B-8911-E4641CE5F784Q40592880-69C84F07-2D72-4FB9-9FBD-47453C48C4CC
P2860
Genetic markers of widespread extensively drug-resistant Pseudomonas aeruginosa high-risk clones.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Genetic markers of widespread ...... s aeruginosa high-risk clones.
@en
type
label
Genetic markers of widespread ...... s aeruginosa high-risk clones.
@en
prefLabel
Genetic markers of widespread ...... s aeruginosa high-risk clones.
@en
P2093
P2860
P50
P356
P1476
Genetic markers of widespread ...... as aeruginosa high-risk clones
@en
P2093
Alain A Ocampo-Sosa
Antonio Oliver
Bartolomé Moyà
Carmen Peña
Cristina Rodríguez
Gabriel Cabot
Juan F Gago
Spanish Network for Research in Infectious Diseases (REIPI)
P2860
P304
P356
10.1128/AAC.01388-12
P407
P577
2012-10-08T00:00:00Z